If You Can't Measure It, You Can't Manage It

Patients receiving ketamine therapy for depression and/or pain must be carefully monitored to keep their symptoms in check.

Using our text mesaging technology we collect and chart your patients' mood data so that you can provide better patient care and increase practice profitability.

Mood monitoring patients actually use

Only 11% of patients will keep a pen and paper mood journal. 1

However, daily mood rating via text messaging has a compliance rate greater than 90%. 2

Phone 121a62c21f2484fa5f82221dbf98477a71b85326d3ede112dfdc990710ded724
Chart 51b89ab4d9fc850c70a9e61aabc49e2aed5f9a3cf07116393647d26069a045d4

Prevent patients from waiting too long to seek boosters

Self-tracking helps patients become more mindfull of their mood, allowing them to seek help before they fully relapse.

Patients can see their mood chart at any time and if they see it start to dip they will often schedule a booster so they don't fall into the "red" zone.

Also, they can share their mood data with their therapists, thereby improving coordination of care.

Know how your patients are doing at all times

You need to know how your patients are doing and if they are in need of additional care.

The American Psychiatric Association's Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders states, "treating clinicians should be able to ensure that rapid follow-up evaluations of patients’ psychiatric symptoms can be provided as needed." 3

With our patient dashboard and reporting tools, you will have the up-to-data you need to provide the proper standard of care for your patients without wasting costly staff time on follow-up calls and emails.

Patients d50312bb6ee40fd80456f902131ae57b9b1d570dc456d4dee4d35baa240d27df
Journal 94d9d3886fb93a81345566a7fd7357be24fcb3f9a6ca4586504fdb454d9ca1ab

We use clinically verified surveys

Every day patients receive a single scale mood question that was found to be a reliable and valid survey instrument by John Hopkins University. 2

To provide more in-depth data collection of specific symptoms, the well validated depression severity survey, the PHQ-9, 4 is given to patients before each treatment and also texted post-treatment on a schedule set by the doctor.

In the fall of 2017, we will be adding the Brief Pain Inventory to help you monitor pain patients as well.

1. Stone AA, Shiffman S, Schwartz JE, Broderick JE, Hufford MR. Patient compliance with paper and electronic diaries. Control Clin Trials. 2003 Apr;24(2):182–99.

2. Foreman AC, Hall C, Bone K, Cheng J, Kaplin A. Just text me: using SMS technology for collaborative patient mood charting. J Participat Med. 2011 Sept 26; 3:e45.

3. Sanacora G, Frye MA, McDonald W, Mathew SJ, Turner MS, Schatzberg AF, Summergrad P, Nemeroff CB, for the American Psychiatric Association (APA) Council of Research Task Force on Novel Biomarkers and Treatments. A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders. JAMA Psychiatry. 2017;74(4):399-405.

Spitzer RL, Kroenke K, Williams JBW, and the Patient Health Questionnaire Study Group. Validity and utility of a self-report version of PRIME-MD: the PHQ Primary Care Study. JAMA.1999;282:1737-1744